EMA Compassionate Use Programme

Regulatory Framework

EU Regulation 726/2004 Article 83

Eligibility Criteria

Patient group with chronically or seriously debilitating disease or life-threatening condition; no authorized treatment available; patient cannot enter clinical trial; medicinal product subject to marketing authorization application or clinical trials

Available Drugs (0)

No drugs linked to this program.